Quantification of immunofluorescence showed a 32.75% increase in the anti-PD1 monotherapy tumor and a 36.42% increase in the anti-PD1 + RT tumor compared to the IgG control (p = 0.017 and p = 0.048, respectively, Welch’s t-test). Here, PDCD1 is linked to neoplasm.